These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23337457)

  • 21. Histamine, mast cells, and the enteric nervous system in the irritable bowel syndrome, enteritis, and food allergies.
    Wood JD
    Gut; 2006 Apr; 55(4):445-7. PubMed ID: 16531524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome.
    Barbara G; Wang B; Stanghellini V; de Giorgio R; Cremon C; Di Nardo G; Trevisani M; Campi B; Geppetti P; Tonini M; Bunnett NW; Grundy D; Corinaldesi R
    Gastroenterology; 2007 Jan; 132(1):26-37. PubMed ID: 17241857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Visceral hypersensitivity in irritable bowel syndrome.
    Kanazawa M; Hongo M; Fukudo S
    J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():119-21. PubMed ID: 21443723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
    Barbara G; Zecchi L; Barbaro R; Cremon C; Bellacosa L; Marcellini M; De Giorgio R; Corinaldesi R; Stanghellini V
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of mast cells in functional GI disorders.
    Wouters MM; Vicario M; Santos J
    Gut; 2016 Jan; 65(1):155-68. PubMed ID: 26194403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome.
    Cremon C; Carini G; Wang B; Vasina V; Cogliandro RF; De Giorgio R; Stanghellini V; Grundy D; Tonini M; De Ponti F; Corinaldesi R; Barbara G
    Am J Gastroenterol; 2011 Jul; 106(7):1290-8. PubMed ID: 21427712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Irritable bowel syndrome: new findings in pathophysiological and therapeutic field.
    Catanzaro R; Occhipinti S; Calabrese F; Anzalone MG; Milazzo M; Italia A; Marotta F
    Minerva Gastroenterol Dietol; 2014 Jun; 60(2):151-63. PubMed ID: 24780949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How can we achieve relief of bowel and abdominal symptoms for patients with irritable bowel syndrome with constipation?
    Tack J
    Expert Rev Gastroenterol Hepatol; 2013 Jul; 7(5 Suppl 1):21-6. PubMed ID: 23859757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antinociceptive effect of chronic lithium on visceral hypersensitivity in a rat model of diarrhea-predominant irritable bowel syndrome: The role of nitric oxide pathway.
    Shamshiri H; Paragomi P; Paydar MJ; Moezi L; Bahadori M; Behfar B; Ardalan FA; Dehpour AR
    J Gastroenterol Hepatol; 2009 Apr; 24(4):672-80. PubMed ID: 19032458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review article: Associations between immune activation, intestinal permeability and the irritable bowel syndrome.
    Matricon J; Meleine M; Gelot A; Piche T; Dapoigny M; Muller E; Ardid D
    Aliment Pharmacol Ther; 2012 Dec; 36(11-12):1009-31. PubMed ID: 23066886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Local immune response to food antigens drives meal-induced abdominal pain.
    Aguilera-Lizarraga J; Florens MV; Viola MF; Jain P; Decraecker L; Appeltans I; Cuende-Estevez M; Fabre N; Van Beek K; Perna E; Balemans D; Stakenborg N; Theofanous S; Bosmans G; Mondelaers SU; Matteoli G; Ibiza Martínez S; Lopez-Lopez C; Jaramillo-Polanco J; Talavera K; Alpizar YA; Feyerabend TB; Rodewald HR; Farre R; Redegeld FA; Si J; Raes J; Breynaert C; Schrijvers R; Bosteels C; Lambrecht BN; Boyd SD; Hoh RA; Cabooter D; Nelis M; Augustijns P; Hendrix S; Strid J; Bisschops R; Reed DE; Vanner SJ; Denadai-Souza A; Wouters MM; Boeckxstaens GE
    Nature; 2021 Feb; 590(7844):151-156. PubMed ID: 33442055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome.
    Park JH; Rhee PL; Kim HS; Lee JH; Kim YH; Kim JJ; Rhee JC
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):71-8. PubMed ID: 16706815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome: The role of proteases.
    Ceuleers H; Van Spaendonk H; Hanning N; Heirbaut J; Lambeir AM; Joossens J; Augustyns K; De Man JG; De Meester I; De Winter BY
    World J Gastroenterol; 2016 Dec; 22(47):10275-10286. PubMed ID: 28058009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ketotifen use in a patient with fire ant hypersensitivity and mast cell activation syndrome.
    Asawa A; Simpson KH; Bonds RS
    Ann Allergy Asthma Immunol; 2015 Jun; 114(6):443-6. PubMed ID: 25868710
    [No Abstract]   [Full Text] [Related]  

  • 35. Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons.
    Balestra B; Vicini R; Cremon C; Zecchi L; Dothel G; Vasina V; De Giorgio R; Paccapelo A; Pastoris O; Stanghellini V; Corinaldesi R; De Ponti F; Tonini M; Barbara G
    Neurogastroenterol Motil; 2012 Dec; 24(12):1118-e570. PubMed ID: 22937879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mast cells count and serum cytokine levels in patients with irritable bowel syndrome.
    Goral V; Kucukoner M; Buyukbayram H
    Hepatogastroenterology; 2010; 57(101):751-4. PubMed ID: 21033222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study.
    Corinaldesi R; Stanghellini V; Cremon C; Gargano L; Cogliandro RF; De Giorgio R; Bartesaghi G; Canovi B; Barbara G
    Aliment Pharmacol Ther; 2009 Aug; 30(3):245-52. PubMed ID: 19438846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Visceral hypersensitivity in IBS: from bench to bedside.
    van Diest SA; Stanisor OI; de Jonge WJ; Boeckxstaens GE; van den Wijngaard RM
    J Pediatr Gastroenterol Nutr; 2011 Dec; 53 Suppl 2():S34-5. PubMed ID: 22235465
    [No Abstract]   [Full Text] [Related]  

  • 39. Mucosal mast cells mediate motor response induced by chronic oral exposure to ovalbumin in the rat gastrointestinal tract.
    Traver E; Torres R; de Mora F; Vergara P
    Neurogastroenterol Motil; 2010 Jan; 22(1):e34-43. PubMed ID: 19682267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Irritable bowel syndrome: is the colonic mucosa to blame?
    Hoffman JM
    Neurogastroenterol Motil; 2012 Dec; 24(12):1051-3. PubMed ID: 23176660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.